Mohsen Bazargan1,2, Anna Lucas-Wright1,3, Loretta Jones1,3, Roberto Vargas2, Jaydutt V Vadgama1, Shirley Evers-Manly1, Annette E Maxwell4. 1. 1 Charles R. Drew University of Medicine and Science , Los Angeles, California. 2. 3 David Geffen School of Medicine, University of California Los Angeles , Los Angeles, California. 3. 2 Healthy African American Families , Los Angeles, California. 4. 4 Fielding School of Public Health and Jonsson Comprehensive Cancer Center, University of California Los Angeles , Los Angeles, California.
Abstract
BACKGROUND: African American women have lower 5-year cancer survival rates than non-Latino White women. Differences in perceived benefits of early cancer detection among racial/ethnic groups may affect cancer-screening behaviors. This study assessed correlates of perceived benefits of early breast, cervical and colorectal cancer detection among 513 African American women. METHODS: Using a community-partnered participatory research approach, we conducted a survey on cancer screening, risk behaviors, and related knowledge and attitudes among African American parishioners at 11 churches in South Los Angeles, a neighborhood that experiences one of the highest cancer mortality rates in California. RESULTS: African American women who participated in this study were more likely to believe that chances for survival are very good or good after early detection of breast cancer (74%) than after early detection of colorectal (51%) and cervical cancer (52%). Multivariate analyses show that perceived benefit of early cancer detection is associated with higher cancer knowledge and having discussed one's cancer risk with a doctor. CONCLUSIONS: Given that 5-year survival rates for early stage breast, cervical, and colorectal cancer range from 84% to 93%, our data suggest that a substantial proportion of African American women in South Los Angeles are not aware of the benefits of early detection, particularly of colorectal and cervical cancers. Programs that increase cancer knowledge and encourage a discussion of individual's cancer risk with a doctor may be able to increase perceived benefit of early detection, a construct that has been shown to be associated with cancer screening in some studies.
BACKGROUND: African American women have lower 5-year cancer survival rates than non-Latino White women. Differences in perceived benefits of early cancer detection among racial/ethnic groups may affect cancer-screening behaviors. This study assessed correlates of perceived benefits of early breast, cervical and colorectal cancer detection among 513 African American women. METHODS: Using a community-partnered participatory research approach, we conducted a survey on cancer screening, risk behaviors, and related knowledge and attitudes among African American parishioners at 11 churches in South Los Angeles, a neighborhood that experiences one of the highest cancer mortality rates in California. RESULTS: African American women who participated in this study were more likely to believe that chances for survival are very good or good after early detection of breast cancer (74%) than after early detection of colorectal (51%) and cervical cancer (52%). Multivariate analyses show that perceived benefit of early cancer detection is associated with higher cancer knowledge and having discussed one's cancer risk with a doctor. CONCLUSIONS: Given that 5-year survival rates for early stage breast, cervical, and colorectal cancer range from 84% to 93%, our data suggest that a substantial proportion of African American women in South Los Angeles are not aware of the benefits of early detection, particularly of colorectal and cervical cancers. Programs that increase cancer knowledge and encourage a discussion of individual's cancer risk with a doctor may be able to increase perceived benefit of early detection, a construct that has been shown to be associated with cancer screening in some studies.
Authors: Anna Lucas-Wright; Mohsen Bazargan; Loretta Jones; Jaydutt V Vadgama; Roberto Vargas; Marianna Sarkissyan; James Smith; Hamed Yazdanshenas; Annette E Maxwell Journal: J Community Health Date: 2014-02
Authors: Robert A Smith; Deana Manassaram-Baptiste; Durado Brooks; Vilma Cokkinides; Mary Doroshenk; Debbie Saslow; Richard C Wender; Otis W Brawley Journal: CA Cancer J Clin Date: 2014-01-09 Impact factor: 508.702
Authors: Jennifer D Allen; Shirley Morrison Bluethmann; Margaret Sheets; Kelly Morrison Opdyke; Kathryn Gates-Ferris; Marc Hurlbert; Elizabeth Harden Journal: BMC Public Health Date: 2013-12-12 Impact factor: 3.295
Authors: Corrado De Vito; Claudio Angeloni; Emma De Feo; Carolina Marzuillo; Amedeo Lattanzi; Walter Ricciardi; Paolo Villari; Stefania Boccia Journal: Biomed Res Int Date: 2014-06-12 Impact factor: 3.411
Authors: Rhoda K Wanyenze; John Baptist Bwanika; Jolly Beyeza-Kashesya; Shaban Mugerwa; Jim Arinaitwe; Joseph K B Matovu; Violet Gwokyalya; Dickson Kasozi; Justine Bukenya; Fred Makumbi Journal: Glob Health Action Date: 2017 Impact factor: 2.640
Authors: Martin Metzenmacher; Renáta Váraljai; Balazs Hegedüs; Igor Cima; Jan Forster; Alexander Schramm; Björn Scheffler; Peter A Horn; Christoph A Klein; Tibor Szarvas; Hennig Reis; Nicola Bielefeld; Alexander Roesch; Clemens Aigner; Volker Kunzmann; Marcel Wiesweg; Jens T Siveke; Martin Schuler; Smiths S Lueong Journal: Cancers (Basel) Date: 2020-02-04 Impact factor: 6.639
Authors: Michael Lake; Christine S Shusted; Hee-Soon Juon; Russell K McIntire; Charnita Zeigler-Johnson; Nathaniel R Evans; Gregory C Kane; Julie A Barta Journal: BMC Cancer Date: 2020-06-16 Impact factor: 4.430